<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="description" content="priority-pathogens">
<title>Lassa fever (LASV) â€¢ priority-pathogens</title>
<!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
<link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png">
<link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png">
<link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png">
<link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png">
<script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Lassa fever (LASV)">
<meta property="og:description" content="priority-pathogens">
<meta property="og:image" content="/logo.png">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">priority-pathogens</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">3.0.0</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="active nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/pathogen_lassa.html">Lassa fever (LASV)</a>
    <a class="dropdown-item" href="../articles/pathogen_marburg.html">Marburg Virus Disease (MVD)</a>
    <a class="dropdown-item" href="../articles/pathogen_sars.html">Severe acute respiratory syndrome (SARS)</a>
  </div>
</li>
      </ul>
<form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off">
</form>

      <ul class="navbar-nav">
<li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/mrc-ide/priority-pathogens/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
</div>

    
  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Lassa fever (LASV)</h1>
            
            <h4 data-toc-skip class="date">Latest update:
2024-08-19</h4>
      
      <small class="dont-index">Source: <a href="https://github.com/mrc-ide/priority-pathogens/blob/HEAD/vignettes/pathogen_lassa.Rmd" class="external-link"><code>vignettes/pathogen_lassa.Rmd</code></a></small>
      <div class="d-none name"><code>pathogen_lassa.Rmd</code></div>
    </div>

    
    
<p>In 2018, the World Health Organization (WHO) published a list of nine
known pathogens (in addition to an unknown <em>Pathogen X</em>) for
research and development (R&amp;D) prioritisation, due to both their
epidemic and pandemic potential and the absence of licensed vaccines or
therapeutics. Among these prioritised pathogens is Lassa fever.</p>
<p>The Pathogen Epidemiology Review Group (PERG) has published a
systematic review for LASV, if you use any of our results please cite
our paper:</p>
<blockquote>
<p><span class="citation">@article</span>{lassa_doohan_2023, author =
{Doohan et al}, year={2024},<br>
title={Lassa fever outbreaks, mathematical models, and disease
parameters: a systematic review and meta-analysis},<br>
doi = {10.1101/2024.03.23.24304596}, publisher = {Cold Spring Harbor
Laboratory Press}, URL = {<a href="https://www.medrxiv.org/content/10.1101/2024.03.23.24304596v1" class="external-link uri">https://www.medrxiv.org/content/10.1101/2024.03.23.24304596v1</a>},
eprint = {}, journal = {medRxiv} }</p>
</blockquote>
<p>All Figures from the paper are re-produced below on the
<strong>latest</strong> available data in our data set. For convenience
we label the Figures with the same numbers as in the paper.</p>
<style type="text/css">
.flextable-shadow-host{
  overflow: scroll;
  white-space: nowrap;
}
</style>
<p><strong>Figure 1:</strong> Please see the pre-print for the the
PRISMA flowchart. This will remain static as data in the database is
updated.</p>
<div class="section level2">
<h2 id="seroprevalence">Seroprevalence<a class="anchor" aria-label="anchor" href="#seroprevalence"></a>
</h2>
<p>LASV seroprevalence (%) in population and community settings (general
population) of West Africa. (A) Mean LASV seroprevalence (%) from
studies conducted between 1965 and 1992 (target antibodies not specified
in the papers). (B) Mean LASV seroprevalence (%) using IgG assays from
studies conducted between 1993 and 2018. Subnational estimates are shown
at administrative level 1. Green asterisks show reported LASV outbreak
locations and grey areas show absence of estimates. The dotted grey box
in panel (A) shows the corresponding area depicted in panel (B).</p>
<p><strong>Figure 2A:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_2A-1.png" width="1056"></p>
<p><strong>Figure 2B:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_2B-1.png" width="1056"></p>
</div>
<div class="section level2">
<h2 id="severity">Severity<a class="anchor" aria-label="anchor" href="#severity"></a>
</h2>
<p>Case fatality ratio (CFR) meta-analyses using logit-transformed
proportions and a generalised linear mixed-effects model. (A) CFR
estimates by LASV lineage region, inferred from location as reported in
each study. (B) Reported geographic distribution of LASV lineages. (C)
CFR estimates by country. (D) CFR estimates by total number of reported
cases. (E) CFR estimates by population group under study. Red squares
show total common and random effects by subgroup and diamonds show an
overall common effect estimate, where data are pooled and assumed to
come from a single data-generating process with one common CFR, and an
overall random effect estimate, which allows the CFR to vary by study
and assigns different weights when calculating an overall estimate
(appendix section A.3). The number of events corresponds to the number
of reported deaths. Individual study estimates and further subgroup
decompositions are shown in appendix figures B.5-B.9.</p>
<p><strong>Figure 3A:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_3A-1.png" width="864"></p>
<p><strong>Figure 3B:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_3B-1.png" width="864"></p>
<p><strong>Figure 3C:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_3C-1.png" width="864"></p>
<p><strong>Figure 3D:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_3D-1.png" width="864"></p>
<p><strong>Figure 3E:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_3E-1.png" width="864"></p>
</div>
<div class="section level2">
<h2 id="delays">Delays<a class="anchor" aria-label="anchor" href="#delays"></a>
</h2>
<p>Overview of LASV epidemiological delays and mean symptom onset to
hospital admission delay meta-analysis. (A) Estimates of the incubation
period. (B) Estimates of the symptom onset to hospital admission delay.
(C) Estimates of hospital admission to recovery, death, or unspecified
outcome delay. (D) Estimates of symptom onset to recovery or death
delay. Circles, squares and triangles represent mean, median and
unspecified estimates respectively. Thin solid lines are uncertainty
intervals and thick shaded lines the range across central estimates of
disaggregated parameters (e.g., regions, time, age, sex). (E)
Meta-analysis of mean symptom onset to hospital admission delay. Blue
squares are individual study estimates and diamonds show common and
random effect estimates. Hypothetical symptom onset to hospital
admission delay probability distributions are shown in Appendix Figure
B.4.</p>
<p><strong>Figure 4A:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_4A-1.png" width="768"></p>
<p><strong>Figure 4B:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_4B-1.png" width="768"></p>
<p><strong>Figure 4C:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_4C-1.png" width="768"></p>
<p><strong>Figure 4D:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_4D-1.png" width="768"></p>
<p><strong>Figure 4E:</strong></p>
<p><img src="pathogen_lassa_files/figure-html/Figure_4E-1.png" width="960"></p>
</div>
<div class="section level2">
<h2 id="transmission-parameters">Transmission Parameters<a class="anchor" aria-label="anchor" href="#transmission-parameters"></a>
</h2>
<p>Overview of LASV (A) reproduction numbers, (B) growth rates, (C)
attack rates, (D) percentage human to human transmission contribution,
LASV genome (E) evolutionary rates for each protein-encoding gene and,
(F) substitution rates for both genome segments. Both E and F are
measured in nucleotide substitutions per site per year (s/s/y). Circles
and triangles represent mean (panels A and E) and unspecified (panels
A-F) estimates respectively. Thin solid lines are uncertainty intervals
and thick shaded lines the range across central estimates of
disaggregated parameters (e.g., regions, time, age, sex).</p>
<div class="section level3">
<h3 id="reproduction-numbers">Reproduction numbers<a class="anchor" aria-label="anchor" href="#reproduction-numbers"></a>
</h3>
<p><strong>Figure 5 (A):</strong></p>
<p><img src="pathogen_lassa_files/figure-html/R0_eff-1.png" width="768"></p>
</div>
<div class="section level3">
<h3 id="growth-rate">Growth rate<a class="anchor" aria-label="anchor" href="#growth-rate"></a>
</h3>
<p><strong>Figure 5 (B):</strong></p>
<p><img src="pathogen_lassa_files/figure-html/growth_rate-1.png" width="864"></p>
</div>
<div class="section level3">
<h3 id="attack-rate">Attack rate<a class="anchor" aria-label="anchor" href="#attack-rate"></a>
</h3>
<p><strong>Figure 5 (C):</strong></p>
<p><img src="pathogen_lassa_files/figure-html/attack_rate-1.png" width="864"></p>
</div>
<div class="section level3">
<h3 id="human-to-human-transmission-contribution">Human-to-human transmission contribution<a class="anchor" aria-label="anchor" href="#human-to-human-transmission-contribution"></a>
</h3>
<p><img src="pathogen_lassa_files/figure-html/figure_5D-1.png" width="768"></p>
</div>
<div class="section level3">
<h3 id="molecular-evolutionary-rates">Molecular evolutionary rates<a class="anchor" aria-label="anchor" href="#molecular-evolutionary-rates"></a>
</h3>
<p><strong>Figure 5 (E):</strong></p>
<p><img src="pathogen_lassa_files/figure-html/figure_5E-1.png" width="768"></p>
<p><strong>Figure 5 (F):</strong></p>
<p><img src="pathogen_lassa_files/figure-html/figure_5F-1.png" width="768"></p>
</div>
</div>
<div class="section level2">
<h2 id="figures-from-the-supplementary-information">Figures from the Supplementary Information<a class="anchor" aria-label="anchor" href="#figures-from-the-supplementary-information"></a>
</h2>
<p>Quality Assessment</p>
<p><img src="pathogen_lassa_files/figure-html/qa-1.png" width="768"></p>
<p>PDFs</p>
<p><img src="pathogen_lassa_files/figure-html/pdfs-1.png" width="768"></p>
</div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="pkgdown-footer-left">
  <p></p>
<p>Developed by Rebecca Nash, Christian Morgenstern, Sangeeta Bhatia, Richard Sheppard, Joseph Hicks, Gina Cuomo-Dannenburg, Ruth McCabe, Kelly McCain, Patrick Doohan, Tristan Naidoo.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p>
<p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer>
</div>

  

  

  </body>
</html>
